Physician profile
Jorge E Bilbao
NPI 1881626877
$812.50
in general payments reported to CMS, 2019-2025
5 companies · $105 in 2025
The $105 reported for 2025 was more than what a typical Cytopathology provider received nationally (typical 2025 total: $55.75).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $400 · 2020: $18.98 · 2021: $34.53 · 2022: $165 · 2023: $87.08 · 2024: $3.08 · 2025: $105.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $192 · Education: $3.08.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $191.59 |
| Education | $3.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alexion Pharmaceuticals, INC. | $560.83 | 2019-2023 | Ultomiris |
| Adaptive Biotechnologies Corporation | $144.08 | 2022-2023 | Clonoseq |
| Recordati_rare_diseases_inc. | $80.35 | 2025 | Sylvant |
| Astrazeneca Pharmaceuticals LP | $24.16 | 2025 | Enhertu |
| Travere Therapeutics, INC. | $3.08 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jorge Bilbao listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.